Alaunos Therapeutics Inc TCRT:NASDAQ

Last Price$1.30NASDAQ Previous Close - Last Trade as of 4:00PM ET 7/01/22

Today's Change+0.06(4.84%)
Bid (Size)$1.22 (1)
Ask (Size)$1.30 (50)
Day Low / High$1.24 - 1.48
Volume3.6 M

Alaunos Therapeutics Doses First Patient in Phase 1/2 Trial of TCR-T Cell Therapy in Solid Tumors

10:49AM ET 5/02/2022 MT Newswires
Alaunos Therapeutics (TCRT) said Monday it has dosed the first patient in a phase 1/2 trial of TCR-T cell therapy for patients with solid tumors.

The trial is enrolling patients with certain types of cancer across three dose groups to determine the maximum tolerated dose, recommended phase 2 dose and safety profile.

Alaunos expects initial data readout from the phase 1/2 trial in the second half of 2022.

Shares of the company declined 4.7% in recent trading activity.

Price: 0.51, Change: -0.03, Percent Change: -4.70